Although there are a few evidences of EIF3 complex expression roles in cancer development (23), in recent investigations, EIF3 overexpression has been observed in breast and prostate cancer (24); also high level expression of EIF3-p110 subunit has been seen in testicular seminoma (24, 25). This evidence concerns the gene EIF3A and prostate cancer.